Feasibility Study of the Reia Vaginal Pessary
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kris Strohbehn, MD
Dartmouth-Hitchcock Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Boston Urogynecology Associates
Cambridge, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- New York Medical College
Hawthorne, New York, United States
- Main Line Health
Media, Pennsylvania, United States
- Women & Infants Hospital
Providence, Rhode Island, United States
- Uthealth
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2021
- Primary completion
- 16 Jun 2023
- Completion
- 16 Jun 2023
- Last update posted
- 27 Nov 2024
- Registered enrollment
- 78
- Registry id
- NCT04508335
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.